Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The revised joint guidelines.

O Faergeman1

  • 1Department of Internal Medicine and Cardiology, Faculty of Health Sciences, Aarhus University Hospital AAS, Tage-Hansensgade 2, DK-8000 Aarhus C, Denmark.

Atherosclerosis. Supplements
|April 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial fibrillation and upper limb thromboembolectomy: a national cohort study.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Upper-limb thrombo-embolectomy: national cohort study in Denmark.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2010
Same author

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial.

Journal of internal medicine·2010
Same author

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial.

Lancet (London, England)·2008
Same author

[Familial hypercholesterolemia in St. Petersburg: diversity of mutations argues against a strong founder effect].

Genetika·2007
Same author

Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons.

Journal of epidemiology and community health·2006
Same journal

'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members.

Atherosclerosis. Supplements·2021
Same journal

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool.

Atherosclerosis. Supplements·2021
Same journal

Lipid Clinics Network. Rationale and design of the EAS global project.

Atherosclerosis. Supplements·2021
Same journal

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives.

Atherosclerosis. Supplements·2021
Same journal

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project.

Atherosclerosis. Supplements·2021
Same journal

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies.

Atherosclerosis. Supplements·2021
See all related articles

New European guidelines prioritize coronary heart disease (CHD) prevention for high-risk individuals. Evidence-based lifestyle changes and drug therapies aim to reduce cardiovascular events and improve patient quality of life.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Coronary heart disease (CHD) remains a leading cause of morbidity and mortality.
  • Effective prevention strategies are crucial for managing cardiovascular health.
  • Existing guidelines require updates based on recent scientific evidence.

Purpose of the Study:

  • To present revised European guidelines for CHD prevention in clinical practice.
  • To outline evidence-based recommendations for lifestyle interventions and drug therapies.
  • To establish clear therapeutic goals for managing lipids, blood pressure, and diabetes.

Main Methods:

  • Synthesis of evidence from epidemiological, observational, and clinical trials.
  • Risk assessment based on multiple cardiovascular risk factors.

Related Experiment Videos

  • Development of specific treatment targets for key modifiable risk factors.

    • Main Results:

    • Revised guidelines prioritize individuals at high risk for CHD.
    • Recommendations emphasize a personalized approach based on absolute risk assessment.
    • Specific goals are defined for lipid, blood pressure, and diabetes management.

    Conclusions:

    • Implementation of these guidelines promotes a unified approach to CHD prevention across Europe.
    • Adherence to recommendations is expected to reduce cardiovascular morbidity and mortality.
    • Improved patient quality of life is a key outcome of effective CHD prevention.